Sorainen advised a renowned UK law firm on behalf of its client, an American clinical-stage biopharmaceutical company. The advice concerned clinical trials – our team helped to localise a complex agreement on clinical trials between Belarusian state clinics and the contract research organisation. Apart from its complexity, the project was remarkable since it happened against the backdrop of amendments to clinical trial regulations in Belarus. Head of the Life Sciences sector group Marina Golovnitskaya and associate Yauheni Budchanka handled this project.